









Markets
/
Stocks
/
nasdaq-gnln
/

Greenlane Holdings Inc

GNLN

3.550USD

-0.220-5.84%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

4.92MMarket Cap

LossP/E TTM



Greenlane Holdings Inc

3.550

-0.220-5.84%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is low. The company shows weak stock market performance, in line with its weak fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

25 / 31

Overall Ranking

460 / 4720

Industry

Food & Drug Retailing

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

Target Price

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Greenlane Holdings, Inc. provides global platform for the development and distribution of premium smoking accessories, vape devices, and lifestyle products to producers, processors, specialty retailers, smoke shops, convenience stores, and retail consumers. The Company's segments include Consumer Goods and Industrial Goods. The Consumer Goods segment is focused on serving consumers across wholesale, retail and e-commerce operations - through both its proprietary Greenlane Brands, including Groove, Marley Natural, Keith Haring and Higher Standards, as well as lifestyle products and accessories from brands, such as Storz and Bickel, PAX, and many more. The Industrial Goods segment is focused on serving the brands, operators, and retailers through its wholesale operations by providing ancillary products essential to their growth, such as customizable packaging and supply products, which includes its vaporization solutions offering including CCELL branded products.

Growing

The company is in a growing phase, with the latest annual income totaling USD 13.28M.

Overvalued

The company’s latest PE is 0.03, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 3.01K shares, increasing 18.86% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 4.10K shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -1.00.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 5.87, which is lower than the Food & Drug Retailing industry's average of 6.88. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 788.00K, representing a year-over-year decrease of 70.29%, while its net profit experienced a year-over-year decrease of 422.76%.

Score

Industry at a Glance

Previous score

5.87

Change



Financials

8.76

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.82

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

2.91

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 4.60, which is lower than the Food & Drug Retailing industry's average of 5.07. Its current P/E ratio is 0.03, which is -18.12% below the recent high of 0.03 and 245.63% above the recent low of -0.04.

Score

Industry at a Glance

Previous score

4.60

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 25/31

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Food & Drug Retailing industry's average is 7.50.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 4.09, which is lower than the Food & Drug Retailing industry's average of 7.30. Sideways: Currently, the stock price is trading between the resistance level at 4.06 and the support level at 3.31, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

4.09

Change

-0.21

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(4)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.052

Buy

RSI(14)

52.503

Neutral

STOCH(KDJ)(9,3,3)

59.051

Neutral

ATR(14)

0.260

High Vlolatility

CCI(14)

92.628

Neutral

Williams %R

46.660

Neutral

TRIX(12,20)

0.090

Sell

StochRSI(14)

31.889

Sell

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

3.538

Buy

MA10

3.496

Buy

MA20

3.412

Buy

MA50

3.537

Buy

MA100

2.160

Buy

MA200

1.574

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 3.00, which is lower than the Food & Drug Retailing industry's average of 7.39. The latest institutional shareholding proportion is 0.22%, representing a quarter-over-quarter decrease of 44.84%. The largest institutional shareholder is The Vanguard, holding a total of 4.10K shares, representing 0.30% of shares outstanding, with 1.00% increase in holdings.

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

1.00

L1 Capital Global Opportunities Master Fund Ltd.

555.00

-44.50%

Tower Research Capital LLC

4.00

-50.00%

Armistice Capital LLC

42.00

Sher (Barbara)

17.00

Morgan Stanley & Co. LLC

10.00

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 2.91, which is lower than the Food & Drug Retailing industry's average of 4.67. The company's beta value is 1.63. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.